Lab Owner Pleads Guilty to $89 Million Fraud Scheme
Last week saw two key lab-related cases, with the biggest involving a fraud scheme relating to cancer genetic testing.
Last week saw two key lab-related cases, with the biggest involving a fraud scheme relating to cancer genetic testing.
In the period from Mid-February through mid-March, three different products received first-of-their-kind clearances from the agency.
The owners face fraud charges in two different schemes, one involving urine drug testing and one involving COVID-19 testing.
In this webinar, our expert speakers will share what the end of the COVID-19 PHE will mean for clinical labs and how they can best prepare.
With COVID-19 testing demand all but dried up, labs will have to make—or at least contemplate making—significant changes to their business.